Metraipolis › archive › dc_00e125bac3ff

Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma — Europe PMC PMID:41113459

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41113459
DOI
10.3389/fcell.2025.1639922
License (as archived)
solo-consultazione
Archived
2026-11-09T14:49:41.582Z
SHA-256 of the archived text
cb9e72663df6bc9fc3ffde4dade94c4dabb38eda33bb12237e5846019d2a0670
Stable URL of this page
https://metraipolis.com/documento/dc_00e125bac3ff

How to cite

Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma — Europe PMC PMID:41113459 — Europe PMC (en), https://europepmc.org/article/MED/41113459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00e125bac3ff (Metraipolis archive dc_00e125bac3ff, sha256 cb9e72663df6bc9fc3ffde4dade94c4dabb38eda33bb12237e5846019d2a0670)
BibTeX
@misc{dc00e125bac3ff,
  title = {Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma — Europe PMC PMID:41113459},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41113459},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00e125bac3ff; sha256 cb9e72663df6bc9fc3ffde4dade94c4dabb38eda33bb12237e5846019d2a0670},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41113459. Agents can read the archived copy with the MCP tool read_document.